Skip to main content

Table 3 Clinical outcomes during follow-up

From: Clinical outcomes of bicuspid versus tricuspid aortic valve stenosis after transcatheter aortic valve replacement with self-expandable valves

 

30 days

1 year

   

2-year

 

Type 0 BAV

Type 1

BAV

TAV

P value

Type 0 BAV

Type 1

BAV

TAV

P

value

Type 0

BAV

Type 1

BAV

TAV

P value

All cause mortality (n,%)

2 (2.33)

1 (0.92)

4 (2.68)

0.626

3 (3.49)

4 (3.67)

8 (5.37)

0.794

3 (3.49)

6 (5.50)

9 (6.04)

0.782

Stroke (n,%)

4 (4.65)

6 (5.50)

3 (2.01)

0.278

4 (4.65)

8 (7.34)

5 (3.36)

0.315

4 (4.65)

8 (7.34)

6 (4.03)

0.499

MI (n,%)

0

0

0

-

0

0

0

-

0

0

0

-

Major Bleeding (n,%)

0

2 (1.83)

2 (1.34)

0.688

1 (1.16)

3 (2.75)

3 (2.01)

0.797

1 (1.16)

3 (2.75)

4 (2.68)

0.813

Valve thrombosis (n,%)

0

0

0

-

0

1 (0.92)

0

0.567

0

1 (0.92)

0

0.567

Pacemaker (n,%)

7 (8.14)

15 (13.76)

22 (14.77)

0.323

9 (8.26)

15 (13.76)

22 (14.77)

0.628

10 (11.63)

17 (15.60)

22 (14.77)

0.739

PCI (n,%)

0

0

0

-

1 (1.16)

0

1 (0.67

0.725

2 (2.33)

0

1 (0.67)

0.342

Reintervention (n,%)

0

0

0

-

0

0

1 (0.67)

≥ 0.999

0

1 (0.92)

1 (0.67)

≥ 0.999

Rehospitalization for HF (n,%)

2 (2.33)

0

0

0.062

4 (4.65)

16 (14.68)

9 (6.04)

0.016

11 (12.79)

22 (20.18)

13 (8.72)

0.020

  1. MI myocardial infarction, HF heart failure, PCI percutaneous coronary artery intervention